Phosphatidylserine Assay-to-Batch Calculation for European Supplement Manufacturing

A phosphatidylserine supplement formula can look complete while still confusing two different quantities: the weight of the supplied ingredient powder and the amount of phosphatidylserine that powder contributes. For a European manufacturing project, that confusion can spread from the purchase specification to the batch sheet, label, contract manufacturer, laboratory request, and finished-product release.

The direct answer is: calculate the theoretical ingredient input by dividing the total target amount of phosphatidylserine in the batch by the agreed assay fraction of the exact supplied material. Then treat process loss, analytical variation, fill-weight control, and any justified adjustment as separate, documented decisions. Do not substitute a generic “PS powder” weight, a sample COA result from another route, or a vitamin-and-mineral tolerance table for a product-specific calculation and validation.

This guide connects phosphatidylserine, soy PS, and sunflower PS sourcing with European supplement formulation records. It does not recommend a consumer dose, prescribe an overage, or replace target-market review.

The Short Answer

Build the calculation from five controlled inputs:

1. the intended PS amount per daily portion or finished unit
2. the planned number of saleable units or portions
3. the exact supplier product and source route
4. the assay value and reporting basis authorised by the manufacturer’s procedure
5. separately approved factors for sampling, processing, yield, and release

At its simplest:

Theoretical PS ingredient mass = total target PS mass divided by the ingredient assay fraction

If an ingredient is 20% PS, the assay fraction is 0.20. Buyers must still evaluate the complete ingredient and matrix rather than treating the remainder as an interchangeable filler.

Why Powder Weight and PS Amount Are Not the Same

Assay is the bridge between the two quantities

An RFQ might request “100 kg of phosphatidylserine,” while a formulation might require “100 mg PS per capsule.” Those phrases do not establish whether the first number means 100 kg of commercial ingredient powder or 100 kg of active PS equivalent. The commercial and technical documents must use unambiguous terms.

A purchase description should identify the ingredient, source, product code, assay basis, pack, and commercial quantity. The formulation should separately state the required PS contribution and calculated input. Different assay grades require different weights and can change dosage-form space and processing behaviour.

Source and matrix must stay attached to the number

Do not detach an assay result from the product it describes. Soy and sunflower routes require source-specific review, and the same headline assay does not establish identical composition, physical properties, documents, or application fit.

The calculation record should therefore carry one traceable identity line:

supplier legal entity → source route → product code → specification revision → received lot → COA → batch formula → finished batch

If any item changes, decide whether recalculation, pilot work, label review, or requalification is required. The European source-change guide explains why switching from soya to sunflower PS is more than a name substitution.

The Core Calculation

Use consistent mass units throughout the equation.

1. Target PS per unit × planned units = total theoretical PS required.
2. Total theoretical PS required ÷ authorised assay fraction = theoretical commercial ingredient required.
3. Convert the result into the unit used by the batch scale and purchasing record.

A simple illustrative calculation

Suppose a development batch is designed to contain 100 mg of PS per capsule and produce 10,000 capsules. The theoretical PS requirement is:

100 mg × 10,000 = 1,000,000 mg = 1 kg PS

If the exact commercial ingredient is authorised in the formula at a 20% assay fraction:

1 kg ÷ 0.20 = 5 kg of commercial ingredient

This example only demonstrates mass balance. It is not a recommended serving amount, a Nutranexa batch result, a guaranteed yield, or permission to apply a 20% value to an unspecified product. The real worksheet must use the controlled value and basis approved for the exact quoted material.

Before scaling, run a reverse check:

commercial ingredient input × assay fraction ÷ planned units = theoretical PS per unit

The reverse result should return to the intended target before any separate process adjustment. Independently verify unit conversions, decimal placement, and formula version.

Do not silently mix as-is and dry-basis values

An assay may be expressed on an as-is basis, a dry basis, or another defined basis. Moisture can therefore matter to interpretation, but a buyer should not automatically “correct” a supplier result without knowing the specification method and calculation convention.

Record the basis exactly as stated. If supplier, incoming, and finished-product results use different bases, have the laboratory and quality owner define the conversion and comparability rule. Retain the original result, approved conversion, formula, and reviewer.

A Seven-Step Assay-to-Batch Workflow

Freeze the finished-product target

Regulatory, brand, and formulation teams should first agree what the finished label will declare, how the daily portion is defined, how many units make that portion, and in which European markets the product will be sold.

Directive 2002/46/EC requires the amount of nutrients or other substances with a nutritional or physiological effect to be declared numerically and per portion recommended for daily consumption. It also states that declared values are average values based on the manufacturer’s analysis of the product. That makes the commercial label target and analytical plan part of the same control problem.

Begin with an approved product concept and market review, not a supplier assay used to reverse-engineer a convenient label number.

Lock the exact ingredient route and controlled specification

Collect the current specification, available COA evidence, source and composition information, packaging details, and change-control contact. Confirm that the quote, sample, formula, and purchase order describe the same material.

The specification defines expected requirements; a COA reports a particular lot. Review identity, relevant quality fields, methods, units, limits, and release status together using the PS specification guide y COA review guide.

Define which assay value the master formula uses

Three numbers may appear in the file:

• a nominal or marketed grade
• a specification limit or range
• a measured lot result on the COA

They are not automatically interchangeable. The manufacturer’s authorised procedure must define whether the master formula uses a fixed standard potency, a lot-specific adjustment, a conservative design value, or another validated approach. It must also define when a new result triggers recalculation and who approves the change.

Using each COA result can create unreviewed formula changes; using only a specification minimum creates a different control problem. Document the authorised rule, rationale, and connection to finished-product acceptance.

Calculate theoretical ingredient input

Record the formula and batch identifiers, target and units, daily portion, planned quantity, authorised assay and basis, calculated mass, rounding and scale capability, and independent check.

Keep full precision and round only under the approved procedure and weighing capability. Retain unrounded and issued values.

Keep potency adjustment separate from process adjustment

The assay division normalises ingredient potency. It does not prove what happens during dispensing, sieving, transfer, blending, encapsulation, compression, or packaging.

Any additional input intended to address manufacturing loss or stability must have a separate name, rationale, evidence base, approved factor, and upper boundary. Do not hide such an adjustment by changing the assay cell. Do not invent a generic percentage from another ingredient or product. A justified factor should come from relevant development, scale-up, stability, and analytical evidence and must remain compatible with safety, label accuracy, claims, and national requirements.

Confirm the formula through pilot and finished-product evidence

The calculated input must work in the actual dosage form. Evaluate fill capacity, blend behaviour, segregation risk, weight variation, process yield, and representative finished-product sampling under the intended equipment and sequence.

The site’s PS flowability and blend-uniformity pilot guide covers physical handling. For analytical control, define a method suitable for the matrix and decision. Regulation (EU) 2017/625 requires methods used in official controls to follow applicable Union rules or suitable recognised and validated approaches, and says samples should be taken, handled, and labelled to preserve legal, scientific, and technical validity. A commercial manufacturer should likewise be able to explain method suitability, sampling, units, uncertainty, and result interpretation.

Define sampling location, unit count, pooling, test portion, repeat rules, and investigation triggers before commercial release.

Reconcile and release the commercial batch

Reconcile the ingredient lot and issued quantity, returns, actual units and yield, in-process checks, finished sampling and assay, deviations, label version, market, and final release.

Compare actual output with the authorised formula. Do not convert a yield difference into a potency assumption. Hold and investigate when results or reconciliation do not support the declared amount.

Assay-to-Batch Review Worksheet

Need the Exact PS Route Before You Calculate?

Nutranexa can confirm the available route-specific specification and COA evidence for a quotation, along with the PS purchasing baseline of a 25 kg MOQ and 25 kg net per drum. Use Contactar con Ventas to identify the soy or sunflower route, target grade, intended dosage form, destination market, and document request. Your manufacturer should then authorise the formula value, pilot plan, analytical method, and release criteria for the finished product.

European Label and Control Boundaries

Directive 2002/46/EC links the declared amount to the recommended daily portion and manufacturer analysis. Regulation (EU) No 1169/2011 prohibits misleading information, orders ingredients by weight used, and can require quantitative ingredient declarations when an ingredient is named, emphasised, or characterising.

The Commission’s tolerance guidance gives specific food-supplement tables for vitamins and minerals. Do not copy them as a universal PS tolerance. Phosphatidylserine is an “other substance” in this context, requiring product- and market-specific review.

Other substances are not fully harmonised in the same way across the EU, and Member States may require product notification. Confirm national composition, notification, language, and label rules.

If PS is highlighted through a claim, Regulation (EC) No 1924/2006 adds separate conditions. The calculation does not prove that wording is authorised; use the European PS health-claims guide.

Procurement-to-Production Handoff Checklist

• Quote and purchase order name the exact commercial ingredient and source.
• Current specification revision is approved before the master formula is issued.
• COA, ingredient lot, received drum labels, and internal material code match.
• Formula states the PS target and commercial ingredient input as different fields.
• Assay value, reporting basis, and selection rule are authorised.
• Calculation preserves units and shows an independent check.
• Any process or stability adjustment is separate from potency normalisation.
• Pilot work covers the actual dosage form, equipment, and sequence.
• Finished-product sampling and test method are defined before release.
• Label, formula, and laboratory request use the same daily portion and units.

For outsourced production, include these fields in the contract-manufacturer handoff rather than emailing a standalone assay number.

Common Calculation and Review Mistakes

1. Treating commercial ingredient weight as pure PS weight.
2. Typing “20” into a formula that expects the fraction “0.20.”
3. Mixing milligrams, grams, and kilograms without a visible conversion.
4. Using a COA from a different source, product code, or historical sample.
5. Applying a dry-basis correction to an as-is result, or the reverse.
6. Changing the batch formula for each COA without an authorised potency-adjustment procedure.
7. Hiding process loss or stability adjustment inside the assay value.
8. Copying European vitamin and mineral tolerance ranges to PS.
9. Releasing a batch when reconciliation, finished testing, and label version do not align.

How Verified Nutranexa Facts Fit the Workflow

Nutranexa was founded in 2013 and operates a 110,000+ m2 campus. Its primary export focus includes Europe and North America. The website presents general, soy-source, and sunflower-source PS routes, available specification and COA evidence, factory, packaging, and dispatch imagery, and R&D cooperation.

These facts support supplier identity, route selection, documents, and pack planning. The buyer and manufacturer still own the formula, pilot, analytical plan, label, and release decision.

Fuentes

• Directive 2002/46/EC on food supplements — consolidated text
• Regulation (EU) No 1169/2011 on food information to consumers
• European Commission guidance on tolerances for nutrient values declared on labels
• European Commission: Food supplements and substances other than vitamins and minerals
• Regulation (EU) 2017/625, Article 34 on sampling and laboratory methods
• Regulation (EC) No 1924/2006 on nutrition and health claims

Preguntas frecuentes

How do I calculate the amount of PS ingredient powder needed for a batch?

Multiply the intended PS amount per unit by the planned number of units, keep the mass units consistent, and divide the total target PS mass by the authorised assay fraction of the exact ingredient. For example, 20% is entered as 0.20. The result is the theoretical commercial ingredient input before any separately justified and approved process adjustment.

Should the calculation use the specification minimum or the current lot COA result?

There is no universal choice. The manufacturer’s controlled procedure should define whether the master formula uses a standard potency, lot-specific result, conservative design value, or another validated rule. The decision must match the assay basis, change-control process, finished-product evidence, and label target. Do not switch values informally from batch to batch.

Can I use the European vitamin and mineral tolerance table for phosphatidylserine?

Not as a universal PS tolerance. The Commission guidance gives specific food-supplement tolerances for vitamins and minerals. PS is an other substance, so the manufacturer should obtain market-specific regulatory advice and define a product-appropriate specification, analytical method, uncertainty treatment, label target, and release rule.

Does the input calculation prove the finished capsules contain the declared PS amount?

No. It establishes a theoretical mass balance. Dispensing, transfer, blending, fill variation, sampling, analytical method performance, yield, and stability can affect the evidence available at release and over shelf life. Pilot work, in-process controls, representative finished-product testing, and batch reconciliation are still required.

What should I send a contract manufacturer with the PS specification?

Send the exact supplier and source route, product code, controlled specification revision, available lot COA, authorised assay value and basis, target amount per unit and daily portion, batch size, calculation rule, adjustment policy, sampling and test plan, label version, packaging requirements, and change-control contacts.

Conclusion

A defensible phosphatidylserine batch starts by keeping three records distinct: the PS amount promised for the finished product, the assay of the exact commercial ingredient, and the physical ingredient mass issued to production. Connect them with a reproducible equation, then keep process adjustments, sampling, analytical uncertainty, yield, and release evidence visible rather than hiding them in one percentage.

For European projects, the calculation must also stay connected to the recommended daily portion, manufacturer analysis, label presentation, Member State requirements, and any separate claim review. When identity, basis, formula version, or finished evidence does not align, hold the batch decision and resolve the record chain.

Contactar con Ventas

Planning a European supplement formula? Contact Nutranexa Sales with the destination market, soy or sunflower preference, target grade, dosage form, forecast quantity, and requested specification or COA evidence. Nutranexa can confirm the available PS route, 25 kg MOQ, 25 kg drum baseline, and supporting manufacturing information for your qualification and formulation handoff.

Próximos pasos recomendados

• Revisa el Phosphatidylserine página del producto.
• Comparar Soy PS y Sunflower PS.
• Verificar prueba de fabricación y Calidad e I+D.